CTTH: CTT PHARMACEUTICAL HOLDINGS, INC. discloses a purchase
By AlphaYouPublished Form 4
CTT PHARMACEUTICAL HOLDINGS, INC.
Reporting filer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Purchase in CTT PHARMACEUTICAL HOLDINGS, INC.: 10900 units of CTTH, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | 2026-09-16 | P | Purchase | 10900 | 0.048 | 9,414,456 | 0 days | Filed terms
|
CTTH
- Owner
- CTT PHARMACEUTICAL HOLDINGS, INC.
- Date
- 2026-09-16
- Code
- P
- Action
- Purchase
- Quantity
- 10900
- Price
- 0.048
- Following holdings
- 9,414,456
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: CTTH
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 10900
- transaction Price Per Share: 0.048
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9414456
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- CTT PHARMACEUTICAL HOLDINGS, INC.: CEO, Director.
Original sources
Prepared automatically from public filing data. Report a correction.